At the 12-month follow-up : 87.5% of patients reported significant relief defined as 50% reduction in baseline pain scores Mean VAS pain score dropped from 7.2 at baseline to 2.8 at 12 months KOOS (Knee Injury and Osteoarthritis Outcome Score) improved across all subscales: pain, symptoms, activities of daily living, sport/recreation, and quality of life No serious adverse events were reported across the treatment period The durability of the response at 12 months is particularly notable
Symptoms might include itching, rash, or hives
Why Choose Gardenia Aesthetics & Wellness for Unlocking the Power of Peptide Therapy
The synergy of all three components together Understanding each ingredient individually is important
## **Documentation requirements** Documentation should include: - The diagnosis or condition showing low serum vitamin B12, pernicious anemia, or other diseases classified by B-group deficiencies
See also: GLP-1 Guides | Provider Comparisons Search and AI answer brief Practical answer: BPC-157 vs CJC-1295: Which Is Better
